secwatch.observer — SEC 8-K summary
======================================

Issuer:     OSR Holdings, Inc. (OSRH)
CIK:        0001840425
Form:       8-K
Filed at:   2023-06-28T23:59:59+00:00
Accession:  0000898432-23-000419
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.01, 2.03, 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bellevue Life Sciences issues $200K sponsor note; Nasdaq audit committee deficiency after director resignation
--------------------------------------------------------------------------------

- Issued $200K unsecured promissory note to sponsor; no interest, convertible to units at $10/unit.
- Audit committee now has only two independent directors after director resignation; Nasdaq non-compliance with Rule 5605(c)(2)(A).
- Intends to regain compliance within the cure period under Nasdaq rules.
- Note payable on earlier of Dec 31, 2024 or business combination; repayment from trust only if no deal.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840425/000089843223000419/0000898432-23-000419-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840425/000089843223000419/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0000898432-23-000419

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer